Gunnison Valley Hospital Family Medicine Medicare: Medicare Enrolled Practice Location: 85 N 100 E Ste A, Gunnison, UT 84634 Phone: 435-528-7202 Fax: 435-528-3624 |
Scott J. Walker, Do Family Practice Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 East 100 North, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-2186 |
Gunnison Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 65 East 100 North, Gunnison, UT 84634 Phone: 435-528-7291 Fax: 435-528-3844 |
Kimberly E Beck Md Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 76 East Center, Gunnison, UT 84634 Phone: 435-528-7935 Fax: 435-528-7936 |
Gunnison Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 64 East 100 North, Gunnison, UT 84634 Phone: 435-528-2130 Fax: 435-528-7796 |
News Archive
The clock was about to strike midnight, and Scott Newman was desperately feeding pages into a scanner, trying to prevent thousands of dollars in prescription payments from turning into a pumpkin.
UCLA researchers have identified a compound that can reproduce the effect of exercise in muscle cells in mice. The findings are published in the journal Cell Reports Medicine.
Equation, a healthcare consulting firm, is pleased to announce that it has partnered with Physicians' Alliance of America, Inc. (PAA), a non-profit group purchasing organization, to offer consulting and educational programs to PAA members. PAA seeks to help medical practices save money on the goods and services they regularly use. Now members can benefit from Equation's analytical tools, scientific methodologies and proven operational expertise to optimize the financial and operational health of their practice.
Richard Wolf GmbH is presenting its new system solutions for minimally invasive human medicine at the International Trade Fair for Medical Technology – MEDICA 2016, November 14-17, 2016 – at the newly designed exhibition booth under the motto "feel the spirit of excellence".
In a small study that included 25 patients with hereditary hemorrhagic telangiectasia (a genetic disorder that leads to abnormalities of blood vessels) and severe liver involvement with this disease, patients who received the drug bevacizumab had improved cardiac output and a reduction in the duration and number of episodes of nose bleeds, a potentially life-threatening complication for patients with this disorder, according to a study in the March 7 issue of JAMA.
› Verified 8 days ago